Blog
RSS FeedPosted by Michael Wonder on 04 Sep 2017
Analysis of the agenda for the PBAC 2017/3 meeting
4 September 2017 - The PBAC will consider 66 submissions at its next scheduled meeting in early November. ...
Posted by Michael Wonder on 04 Sep 2017
Decision to award sole supply for nicotine replacement therapy
4 September 2017 - PHARMAC is pleased to announce the approval of an agreement with GSK for the supply of ...
Posted by Michael Wonder on 04 Sep 2017
Statistical and clinical significance
4 September 2017 - In published research, a statistically significant result is often wrongly interpreted as representing a clinically important ...
Posted by Michael Wonder on 03 Sep 2017
Health insurers blamed for rising health care costs
4 September 2017 - Australians blame health insurers for rising costs in the nation’s health care system, new consumer research ...
Posted by Michael Wonder on 03 Sep 2017
Call to fund $5000-a-month drug that 'gives people time'
3 September 2017 - A drug that can give patients with advanced breast cancer a longer life has been approved ...
Posted by Michael Wonder on 03 Sep 2017
Nivolumab in squamous cell carcinoma in the head and neck area: additional benefit for certain patients
1 September 2017 - Significant benefit for patients with progression during or shortly after platinum-based therapy. ...
Posted by Michael Wonder on 02 Sep 2017
Commonwealth of Australia v Sanofi: hearing of Commonwealth's claim commences in Federal Court of Australia
31 August 2017 - A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth ...
Posted by Michael Wonder on 01 Sep 2017
NICE says benefits of breast cancer drug fulvestrant too uncertain to make it cost effective
1 September 2017 - NICE has published draft guidance saying the evidence on using fulvestrant to treat a type of breast ...
Posted by Michael Wonder on 31 Aug 2017
Schedule of Pharmaceutical Benefits - 1 September 2017
1 September 2017 - The September 2017 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Aug 2017
Find common ground on health: Roxon
1 September 2017 - Former health minister Nicola Roxon has warned that Australia’s healthcare leaders need to find common ground ...
Posted by Michael Wonder on 31 Aug 2017
New Zealand Pharmaceutical Schedule - 1 September 2017
1 September 2017 - The September 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Aug 2017
Final NHS green light for Allergan’s IBS-D drug
31 August 2017 - Allergan’s Truberzi has become the first treatment for irritable bowel syndrome with diarrhoea to be reviewed ...
Posted by Michael Wonder on 30 Aug 2017
More Canadians have access to Humira (adalimumab) for the treatment of ulcerative colitis
29 August 2017 - Humira (adalimumab) now reimbursed in British Columbia, Ontario, New Brunswick, Newfoundland and Labrador, Saskatchewan and Yukon. ...
Posted by Michael Wonder on 30 Aug 2017
Making more life-changing medicines available to all Australians
30 August 2017 - The Australian Government is listing almost half a billion dollars’ worth of new medicines, providing sufferers of ...
Posted by Michael Wonder on 29 Aug 2017
Crohn’s disease sufferers get life-changing medication cheaper after Stelara is listed on the PBS
29 August 2017 - It’s the disease that is thought to affect 38,000 Aussies. ...